✦ LIBER ✦

A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation

✍ Scribed by Marta Valle; Enrico Di Salle; Maria Gabriella Jannuzzo; Italo Poggesi; Maurizio Rocchetti; Riccardo Spinelli; Davide Verotta

Book ID: 108640326
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 251 KB
Volume: 59
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2005.02335.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using pharmacokinetic–pharmacodynamic mo

Using pharmacokinetic–pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics

✍ Christina Kurre Olsen; Lise Tøttrup Brennum; Mads Kreilgaard 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 828 KB

The effect of food on the pharmacokineti

The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives

✍ H. L. Elliott; P. A. Meredith; K. McLean; M. A. Hughes; J. L. Reid 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 360 KB

The effect of food on pharmacokinetics a

The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failure

✍ Blanchett, Dennis G; Green, Jeffrey A; Nara, Andrew; Pospisil, Robert; Jarvis, R 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 536 KB

A mechanism-based binding model for the

A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab

✍ Naoto Hayashi; Yuko Tsukamoto; William M. Sallas; Philip J. Lowe 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

Effect of food on the pharmacodynamics a

Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase

✍ L. R. Whitfield; R. H. Stern; A. J. Sedman; R. Abel; D. M. Gibson 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 513 KB

Application of pharmacokinetic–pharmacod

Application of pharmacokinetic–pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice

✍ Evelyn D. Lobo; David M. Soda; Joseph P. Balthasar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

We have shown that intravenous (i.v.) administration of anti-methotrexate (MTX) antibodies (AMAb) reduces the systemic exposure of intraperitoneal (i.p.) MTX therapy, and we have proposed that AMAb effects on MTX systemic exposure would allow a reduction in MTX-induced systemic toxicity (i.e., produ